NL293572A
(fr)
|
1962-06-07 |
|
|
|
CH478818A
(de)
|
1965-10-22 |
1969-09-30 |
Ciba Geigy |
Verfahren zur Herstellung neuer N,N'-Di-(pyrimidyl-(4)-aminoalkyl)-diazacycloalkanen
|
CH480410A
(de)
|
1967-01-09 |
1969-10-31 |
Geigy Ag J R |
Verfahren zur Herstellung von wasserlöslichen Azopyrimidinfarbstoffen
|
CA961052A
(en)
|
1967-01-12 |
1975-01-14 |
Max Schellenbaum |
N-2-ethylhexyl-n'-aryl ureas and preparation containing them
|
US3608087A
(en)
|
1968-06-21 |
1971-09-21 |
Merck & Co Inc |
Feed compositions
|
US3887329A
(en)
|
1969-05-05 |
1975-06-03 |
Ciba Geigy Ag |
Hexamethyl phosphotriamide-dye compositions
|
BE756953A
(fr)
|
1969-10-02 |
1971-04-01 |
Merck & Co Inc |
Potentialisation d'antibiotiques
|
US3686238A
(en)
|
1970-01-19 |
1972-08-22 |
Syntex Corp |
Glycerol esterified with 2-naphthyl-acetic acids and fatty acids
|
US3852434A
(en)
|
1970-09-11 |
1974-12-03 |
Merck & Co Inc |
Potentiation of ({31 ) cis-1,2-epoxypropyl)phosphonic acid and analogues thereof
|
US3966744A
(en)
|
1971-01-11 |
1976-06-29 |
Syva Company |
Spin labeled compounds
|
US3690834A
(en)
|
1971-01-11 |
1972-09-12 |
Syva Co |
Ligand determination with spin labeled compounds by receptor displacement
|
DE2106585A1
(de)
|
1971-02-11 |
1972-08-24 |
Farbenfabriken Bayer Ag, 5090 Leverkusen |
Aminothiodiazole und Thiodiazol-Azofarbstoffe
|
CH558137A
(de)
|
1971-05-17 |
1975-01-31 |
Ciba Geigy Ag |
Mittel zur beeinflussung des pflanzenwachstums.
|
DE2226703A1
(de)
|
1972-05-25 |
1973-12-13 |
Schering Ag |
Neue tetrahydrocarbazolderivate und verfahren zu ihrer herstellung
|
US3966764A
(en)
|
1972-07-10 |
1976-06-29 |
Syva Company |
Ligand determination of spin labeled compounds by receptor displacement-amphetamine analogs
|
US3849420A
(en)
|
1972-10-20 |
1974-11-19 |
Dow Chemical Co |
Bis-(alkylthio-and alkylsulfonyl)-pentachloroquinolines
|
CH574206A5
(fr)
|
1972-11-16 |
1976-04-15 |
Ciba Geigy Ag |
|
DE2340569C2
(de)
|
1973-08-10 |
1982-12-02 |
Bayer Ag, 5090 Leverkusen |
Azofarbstoffe
|
AT340933B
(de)
|
1973-08-20 |
1978-01-10 |
Thomae Gmbh Dr K |
Verfahren zur herstellung neuer pyrimidinderivate und ihrer saureadditionssalze
|
DE2341925A1
(de)
|
1973-08-20 |
1975-03-06 |
Thomae Gmbh Dr K |
Neue pyrimidinderivate und verfahren zu ihrer herstellung
|
US4057559A
(en)
|
1973-10-01 |
1977-11-08 |
American Home Products Corporation |
Carbazole acetic acid derivatives
|
CH584739A5
(fr)
|
1973-12-21 |
1977-02-15 |
Ciba Geigy Ag |
|
US4101541A
(en)
|
1973-12-21 |
1978-07-18 |
Ciba-Geigy Corporation |
3-Cyano-1,2,4-thiadiazolyl-5-czo dyestuffs
|
FR2258841B1
(fr)
|
1974-01-29 |
1977-11-04 |
Ugine Kuhlmann |
|
FR2306697A1
(fr)
|
1975-04-10 |
1976-11-05 |
Sogeras |
Nouvelles pyrimidines utilisables comme medicaments antidiabetiques et hypocholesterolemiants
|
US4139705A
(en)
|
1977-05-20 |
1979-02-13 |
The Dow Chemical Company |
Pyrazolopyrimidines
|
US4189579A
(en)
|
1977-05-20 |
1980-02-19 |
The Dow Chemical Company |
Aminoalkylthiopurines
|
DE2731264A1
(de)
|
1977-07-11 |
1979-02-01 |
Boehringer Mannheim Gmbh |
Neue 1-acyl-2-cyanaziridine, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zubereitungen
|
JPS6038696B2
(ja)
|
1977-12-09 |
1985-09-02 |
コニカ株式会社 |
ハロゲン化銀カラ−写真感光材料
|
US4242507A
(en)
|
1978-02-23 |
1980-12-30 |
Fujisawa Pharmaceutical Co., Ltd. |
Sulfonic acid esters
|
DE2831580C2
(de)
|
1978-07-18 |
1980-09-18 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Verfahren und Reagens zur Bestimmung von Glycerin
|
DE2831850A1
(de)
|
1978-07-20 |
1980-02-07 |
Basf Ag |
N-arylsulfonylpyrrole, ihre herstellung und diese enthaltende therapeutische mittel
|
DE2906603A1
(de)
|
1979-02-21 |
1980-09-04 |
Boehringer Mannheim Gmbh |
N-substituierte aziridin-2-carbonsaeurederivate, verfahren zu deren herstellung sowie diese substanzen enthaltende arzneimittel
|
US4343804A
(en)
|
1979-03-26 |
1982-08-10 |
A. H. Robins Company, Inc. |
4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds
|
EP0053678A1
(fr)
|
1980-12-05 |
1982-06-16 |
BASF Aktiengesellschaft |
Amino-5-phényl-1-cyano-4-pyrazoles, herbicides les contenant, leur procédé de préparation et leur application comme herbicides
|
DOP1981004033A
(es)
|
1980-12-23 |
1990-12-29 |
Ciba Geigy Ag |
Procedimiento para proteger plantas de cultivo de la accion fitotoxica de herbicidas.
|
US4476248A
(en)
|
1983-02-28 |
1984-10-09 |
The Upjohn Company |
Crystallization of ibuprofen
|
DE3334455A1
(de)
|
1983-03-04 |
1984-09-06 |
Bayer Ag, 5090 Leverkusen |
Guanidin - derivate
|
US4612376A
(en)
|
1983-03-25 |
1986-09-16 |
Fujisawa Pharmaceutical Co., Ltd. |
Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent
|
ZA848275B
(en)
|
1983-12-28 |
1985-08-28 |
Degussa |
New piridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring
|
DE3406329A1
(de)
|
1984-02-22 |
1985-08-22 |
Merck Patent Gmbh, 6100 Darmstadt |
Pyridone
|
DE3601196A1
(de)
|
1986-01-17 |
1987-07-23 |
Merck Patent Gmbh |
1,4-dihydropyridine
|
US4810699A
(en)
|
1987-02-20 |
1989-03-07 |
American Home Products Corporation |
Substituted 1,3,4,9-tetrahydropyrano[3,4,-b]indole-1-acetic acids, pharmaceutical compositions containing them, and methods for treating inflammatory conditions and for analgesic purposes using them
|
US4782076A
(en)
|
1988-03-01 |
1988-11-01 |
American Home Products Corporation |
Substituted 2,3,4,9-tetrahydro-1H-carbazole-1-acetic acid derivatives, composition and use
|
PT95692A
(pt)
|
1989-10-27 |
1991-09-13 |
American Home Prod |
Processo para a preparacao de derivados de acidos indole-,indeno-,piranoindole- e tetra-hidrocarbazole-alcanoicos, ou quais sao uteis como inibidores de pla2 e da lipoxigenase
|
US5221678A
(en)
|
1990-07-26 |
1993-06-22 |
Merck Frosst Canada, Inc. |
(quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
|
DE4208254A1
(de)
|
1992-03-14 |
1993-09-16 |
Hoechst Ag |
Substituierte pyrimidine, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel und fungizid
|
TW237456B
(fr)
|
1992-04-09 |
1995-01-01 |
Ciba Geigy |
|
FR2692575B1
(fr)
|
1992-06-23 |
1995-06-30 |
Sanofi Elf |
Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
|
DE4241632A1
(de)
|
1992-12-10 |
1994-06-16 |
Thomae Gmbh Dr K |
Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
US5998499A
(en)
|
1994-03-25 |
1999-12-07 |
Dentsply G.M.B.H. |
Liquid crystalline (meth)acrylate compounds, composition and method
|
CZ101496A3
(en)
|
1993-10-12 |
1996-11-13 |
Du Pont Merck Pharma |
N-alkyl-n-aryl-pyrimidinamines and derivatives thereof
|
TW530047B
(en)
|
1994-06-08 |
2003-05-01 |
Pfizer |
Corticotropin releasing factor antagonists
|
EP0781766B1
(fr)
|
1994-09-09 |
2004-03-31 |
Nippon Shinyaku Company, Limited |
Derive heterocyclique et medicament
|
US5691364A
(en)
|
1995-03-10 |
1997-11-25 |
Berlex Laboratories, Inc. |
Benzamidine derivatives and their use as anti-coagulants
|
US6403599B1
(en)
|
1995-11-08 |
2002-06-11 |
Pfizer Inc |
Corticotropin releasing factor antagonists
|
US6956047B1
(en)
|
1995-06-06 |
2005-10-18 |
Pfizer Inc. |
Corticotropin releasing factor antagonists
|
KR0169813B1
(ko)
|
1995-07-12 |
1999-01-15 |
김종인 |
4-아미노-3-아실나프티리딘 유도체
|
US5849759A
(en)
|
1995-12-08 |
1998-12-15 |
Berlex Laboratories, Inc. |
Naphthyl-substituted benzimidazole derivatives as anti-coagulants
|
US5948786A
(en)
|
1996-04-12 |
1999-09-07 |
Sumitomo Pharmaceuticals Company, Limited |
Piperidinylpyrimidine derivatives
|
US6060478A
(en)
|
1996-07-24 |
2000-05-09 |
Dupont Pharmaceuticals |
Azolo triazines and pyrimidines
|
US5776967A
(en)
|
1996-07-26 |
1998-07-07 |
American Home Products Corporation |
Pyranoindole inhibitors of COX--2
|
AR008789A1
(es)
|
1996-07-31 |
2000-02-23 |
Bayer Corp |
Piridinas y bifenilos substituidos
|
US5830911A
(en)
|
1996-08-14 |
1998-11-03 |
American Home Products Corporation |
Pyranoindole and tetrahydrocarbazole inhibitors of COX-2
|
US6008234A
(en)
|
1996-09-12 |
1999-12-28 |
Berlex Laboratories, Inc. |
Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives and their use as anti-coagulants
|
NL1010018C2
(nl)
|
1997-09-09 |
1999-03-10 |
Duphar Int Res |
Chinoline en chinazoline derivaten met corticotropine releasing factor (CRF) antagonistische werking.
|
GB9722361D0
(en)
*
|
1997-10-24 |
1997-12-17 |
Pharma Nord Uk Ltd |
Pharmaceutical formulation for treating liver disorders
|
US6861448B2
(en)
|
1998-01-14 |
2005-03-01 |
Virtual Drug Development, Inc. |
NAD synthetase inhibitors and uses thereof
|
US6187777B1
(en)
|
1998-02-06 |
2001-02-13 |
Amgen Inc. |
Compounds and methods which modulate feeding behavior and related diseases
|
EP1105394A1
(fr)
|
1998-08-21 |
2001-06-13 |
Du Pont Pharmaceuticals Company |
Isoxazolo 4,5-d]pyrimidines comme antagonistes du crf
|
US6239126B1
(en)
|
1998-12-17 |
2001-05-29 |
American Home Products Corporation |
Arylpiperidine and aryl-1,2,5,6-tetra-hydropyridine urea derivatives
|
EP1140859A2
(fr)
|
1998-12-18 |
2001-10-10 |
Axys Pharmaceuticals, Inc. |
Derives bicycliques (hetero)aryl aryl, leur preparation et leur utilisation comme inhibiteurs de protease
|
CZ27399A3
(cs)
|
1999-01-26 |
2000-08-16 |
Ústav Experimentální Botaniky Av Čr |
Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
SK287238B6
(sk)
|
1999-03-17 |
2010-04-07 |
Astrazeneca Ab |
Amidové deriváty, spôsob ich prípravy, farmaceutická kompozícia, ktorá ich obsahuje, a ich použitie
|
EE200100556A
(et)
|
1999-04-28 |
2003-02-17 |
Aventis Pharma Deutschland Gmbh |
Diarüülhappe derivaat, seda sisaldav farmatseutiline kompositsioon ja ühendi kasutamine ravimite valmistamiseks
|
US6921763B2
(en)
|
1999-09-17 |
2005-07-26 |
Abbott Laboratories |
Pyrazolopyrimidines as therapeutic agents
|
IL148718A0
(en)
|
1999-09-17 |
2002-09-12 |
Abbott Gmbh & Co Kg |
Pyrazolopyrimidines as therapeutic agents
|
US6414002B1
(en)
|
1999-09-22 |
2002-07-02 |
Bristol-Myers Squibb Company |
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
|
BRPI0014271B1
(pt)
|
1999-09-24 |
2021-06-22 |
Janssen Pharmaceutica N.V. |
Partícula consistindo em uma dispersão de sólidos, uso da dita partícula, dispersão de sólidos, forma de dosagem farmacêutica, bem como processos de preparação de dita partícula, dispersão e forma de dosagem
|
YU23802A
(sh)
|
1999-09-30 |
2004-09-03 |
Neurogen Corporation |
Određeni alkilen diamin-supstituisani pirazolo/1,5-a/-1,5- piramidini i pirazolo/1,5-a/1,3,5-triazini
|
NZ517575A
(en)
|
1999-09-30 |
2004-04-30 |
Neurogen Corp |
Certain alkylene diamine-substituted heterocycles
|
IL148904A0
(en)
|
1999-09-30 |
2002-09-12 |
Neurogen Corp |
Amino substituted pyrazolo {1,5,-a}-1,5- pyrimidines and pyrazolo{1,5,-a}-1,3,5-triazines
|
DE19947154A1
(de)
|
1999-10-01 |
2001-10-04 |
Bayer Ag |
Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
|
US6887870B1
(en)
|
1999-10-12 |
2005-05-03 |
Bristol-Myers Squibb Company |
Heterocyclic sodium/proton exchange inhibitors and method
|
GR990100388A
(el)
|
1999-11-09 |
2001-07-31 |
|
Φαρμακευτικος συνδυασμος αποτελουμενος απο χωριστες δοσολογικες μορφες σε συσκευασια συμμορφωσης (compliance package) ενος αναστολεα της αναγωγασης του υδροξυ-μεθυλο-γλουταρυλο συνενζυμου α (στατινης, statin) και ενος παραγωγου του φιμπρικου οξεος....
|
WO2001046204A1
(fr)
|
1999-12-22 |
2001-06-28 |
Merck Frosst Canada & Co. |
Phosphonates aromatiques constituant des inhibiteurs de la phosphatase 1b (ptp-1b) de tyrosine proteique
|
DE19962936A1
(de)
|
1999-12-24 |
2001-06-28 |
Bayer Ag |
Neue beta-Aminosäureverbindungen als Integrinantagonisten
|
EP1246815B1
(fr)
|
1999-12-30 |
2004-03-17 |
H. Lundbeck A/S |
Derives de phenylpiperazinyle
|
KR20020063934A
(ko)
|
2000-01-18 |
2002-08-07 |
화이자 프로덕츠 인코포레이티드 |
코르티코트로핀 방출 인자 길항제
|
IL150841A0
(en)
|
2000-02-09 |
2003-02-12 |
Hokuriku Pharmaceutical |
1h-imidazopyridine derivatives
|
WO2001060870A1
(fr)
|
2000-02-15 |
2001-08-23 |
Foster Miller, Inc. |
Compositions de resine durcissables par rayonnement sans constituant organique volatil
|
EP1259494A4
(fr)
|
2000-02-18 |
2004-09-15 |
Merck & Co Inc |
Acides aryloxyacetiques utilises en cas de diabete et de troubles lipidiques
|
US6569879B2
(en)
|
2000-02-18 |
2003-05-27 |
Merck & Co., Inc. |
Aryloxyacetic acids for diabetes and lipid disorders
|
NZ520241A
(en)
|
2000-02-25 |
2004-05-28 |
F |
Adenosine receptor modulators
|
BR0109966A
(pt)
|
2000-04-12 |
2003-08-05 |
Novartis Ag |
Combinação de compostos orgânicos
|
WO2001085699A2
(fr)
|
2000-05-08 |
2001-11-15 |
Janssen Pharmaceutica N.V. |
Promedicaments a base de pyrimidines inhibant la replication du vih
|
DE10024319A1
(de)
|
2000-05-17 |
2001-11-22 |
Merck Patent Gmbh |
Bisacylguanidine
|
AU2001263288A1
(en)
|
2000-05-18 |
2001-11-26 |
Neurocrine Biosciences, Inc. |
Crf receptor antagonists
|
RU2243222C2
(ru)
|
2000-05-25 |
2004-12-27 |
Ф.Хоффманн-Ля Рош Аг |
Замещенные 1-аминоалкиллактамы, фармацевтическая композиция на их основе и способ их получения
|
US6620821B2
(en)
|
2000-06-15 |
2003-09-16 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors and method
|
CA2413702A1
(fr)
|
2000-06-28 |
2002-01-03 |
Teva Pharmaceuticals Industries Ltd. |
Carvedilol
|
CA2414461A1
(fr)
|
2000-06-29 |
2002-01-10 |
Abbott Laboratories |
Derives d'aryle phenylheterocyclyle sulfures et leur utilisation en tant qu'agents immunosuppresseurs anti-inflammatoires inhibant l'adherence cellulaire
|
AR028782A1
(es)
|
2000-07-05 |
2003-05-21 |
Taisho Pharmaceutical Co Ltd |
Derivados heterociclicos tetrahidropiridino o piperidino
|
US6444685B1
(en)
|
2000-07-17 |
2002-09-03 |
Wyeth |
N-(4-sulfonylaryl)Cyclylamine 2-hydroxyethylamines as beta-3 adrenergic receptor agonists
|
CA2415899A1
(fr)
|
2000-07-18 |
2003-01-13 |
Chikashi Saitoh |
Medicament comprenant un derive de dicyanopyridine
|
WO2002008188A1
(fr)
|
2000-07-25 |
2002-01-31 |
Merck & Co., Inc. |
Indoles n-substitues utiles pour le traitement du diabete
|
US6410583B1
(en)
|
2000-07-25 |
2002-06-25 |
Merck Frosst Canada & Co. |
Cyclopentanoindoles, compositions containing such compounds and methods of treatment
|
AU2001284417A1
(en)
|
2000-09-05 |
2002-03-22 |
Taisho Pharmaceutical Co. Ltd. |
Hair growth stimulants
|
ATE367802T1
(de)
|
2000-09-20 |
2007-08-15 |
Jagotec Ag |
Verfahren zur sprühtrocknung von zusammensetzungen enthaltend fenofibrat
|
US7276249B2
(en)
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US20030224058A1
(en)
|
2002-05-24 |
2003-12-04 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
PE20020507A1
(es)
|
2000-10-17 |
2002-06-25 |
Schering Corp |
Compuestos no-imidazoles como antagonistas del receptor histamina h3
|
WO2002032408A2
(fr)
|
2000-10-20 |
2002-04-25 |
Novartis Ag |
Compositions
|
CA2426654C
(fr)
|
2000-10-23 |
2010-12-21 |
Smithkline Beecham Corporation |
Nouveaux composes
|
CA2427610A1
(fr)
|
2000-10-31 |
2002-08-08 |
Merck & Co., Inc. |
Derives d'acide benzopyranocarboxylique pour traiter le diabete et d'autres troubles lipidiques
|
AU3958902A
(en)
|
2000-11-03 |
2002-05-27 |
Neurocrine Biosciences Inc |
Crf receptor antagonists and methods relating thereto
|
US20020058026A1
(en)
|
2000-11-13 |
2002-05-16 |
Milton Hammerly |
HMG CoA reductase inhibitor medications combined wih CoEnzyme Q-10
|
AU2002223492A1
(en)
|
2000-11-14 |
2002-05-27 |
Neurosearch A/S |
Use of malaria parasite anion channel blockers for treating malaria
|
WO2002040458A1
(fr)
|
2000-11-17 |
2002-05-23 |
Takeda Chemical Industries, Ltd. |
Derives d'isoxazole
|
UA77165C2
(en)
|
2000-11-17 |
2006-11-15 |
Lilly Co Eli |
(n)-((s)-2-hydroxy-3-methyl-butyryl)-1-(l-alaninyl)-(s)-1-amino-3-methyl-4,5,6,7-tetrahydro-2h-3-benzazepin-2-one dihydrate, processes for manufacturing and pharmaceutical composition
|
EP1335907B1
(fr)
|
2000-11-20 |
2010-06-09 |
Biovitrum AB (publ) |
Composes de piperazinylpyrazine utilises comme agonistes ou antagonistes du recepteur de la serotonine 5ht-2
|
EP1770159A1
(fr)
|
2000-12-01 |
2007-04-04 |
Astellas Pharma Inc. |
Procédé de production d'une composition thérapeutique destinée au traitement de diabète
|
US20020137755A1
(en)
|
2000-12-04 |
2002-09-26 |
Bilodeau Mark T. |
Tyrosine kinase inhibitors
|
US20020107262A1
(en)
|
2000-12-08 |
2002-08-08 |
3M Innovative Properties Company |
Substituted imidazopyridines
|
US6545017B1
(en)
|
2000-12-08 |
2003-04-08 |
3M Innovative Properties Company |
Urea substituted imidazopyridines
|
US6525064B1
(en)
|
2000-12-08 |
2003-02-25 |
3M Innovative Properties Company |
Sulfonamido substituted imidazopyridines
|
US6545016B1
(en)
|
2000-12-08 |
2003-04-08 |
3M Innovative Properties Company |
Amide substituted imidazopyridines
|
AU3113902A
(en)
|
2000-12-21 |
2002-07-01 |
Bristol Myers Squibb Co |
Thiazolyl inhibitors of tec family tyrosine kinases
|
US7417039B2
(en)
|
2001-01-26 |
2008-08-26 |
Schering Corporation |
Use of substituted azetidinone compounds for the treatment of sitosterolemia
|
CA2437358A1
(fr)
|
2001-01-30 |
2002-08-22 |
University Of Virginia Patent Foundation |
Agonistes et antagonistes de recepteurs de sphingosine-1-phosphate
|
AU2002240235B2
(en)
|
2001-01-30 |
2006-07-06 |
Merck & Co., Inc. |
Acyl sulfamides for treatment of obesity, diabetes and lipid disorders
|
KR100863622B1
(ko)
|
2001-02-08 |
2008-10-15 |
메모리 파마슈티칼스 코포레이션 |
포스포디에스테라제 4 억제제로서의 트리플루오로메틸푸린
|
JP2004521124A
(ja)
|
2001-02-09 |
2004-07-15 |
メルク エンド カムパニー インコーポレーテッド |
糖尿病および脂質障害用の2−アリールオキシ−2−アリールアルカン酸類
|
DE10110754A1
(de)
|
2001-03-07 |
2002-09-19 |
Bayer Ag |
Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
|
WO2002072101A1
(fr)
|
2001-03-13 |
2002-09-19 |
Bristol-Myers Squibb Pharma Company |
Ligand du recepteur de la corticoliberine, son enantiomere et ses sels pharmaceutiquement acceptables
|
KR100876047B1
(ko)
|
2001-03-29 |
2008-12-26 |
오사까 가스 가부시키가이샤 |
광활성 화합물 및 감광성 수지 조성물
|
WO2002081454A1
(fr)
|
2001-04-09 |
2002-10-17 |
Dr. Reddy's Laboratories Ltd. |
Derives d'acides aryliques et leur utilisation en medecine, procede de preparation de ces derives et compositions pharmaceutiques contenant lesdits derives
|
CA2444095A1
(fr)
|
2001-04-20 |
2002-10-31 |
Wyeth |
Derives d'heterocyclyloxy-, -thioxy- et aminobenzazol servant de ligands de 5-hydroxytryptamine-6
|
ATE416762T1
(de)
|
2001-05-10 |
2008-12-15 |
Ono Pharmaceutical Co |
Carbonsäurederivate und diese als wirkstoff enthaltende arzneimittel
|
DE60234338D1
(de)
|
2001-06-01 |
2009-12-24 |
Hoffmann La Roche |
Pyrimidin, triazin und pyrazinderivate als glutamatrezeptoren
|
JP2005500294A
(ja)
|
2001-06-19 |
2005-01-06 |
ブリストル−マイヤーズ スクイブ カンパニー |
ホスホジエステラーゼ7に対するピリミジン阻害剤
|
US6825198B2
(en)
|
2001-06-21 |
2004-11-30 |
Pfizer Inc |
5-HT receptor ligands and uses thereof
|
JP4510442B2
(ja)
|
2001-06-26 |
2010-07-21 |
ブリストル−マイヤーズ スクイブ カンパニー |
TNF−α発現のN−ヘテロ環インヒビター
|
UA74912C2
(en)
|
2001-07-06 |
2006-02-15 |
Merck & Co Inc |
Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
|
GB0117899D0
(en)
|
2001-07-23 |
2001-09-12 |
Astrazeneca Ab |
Chemical compounds
|
WO2003026661A1
(fr)
|
2001-09-14 |
2003-04-03 |
Yamanouchi Pharmaceutical Co., Ltd. |
Accelerateur de secretion de l'insuline et nouveau derive de pyrimidine
|
MXPA04002679A
(es)
|
2001-09-27 |
2004-07-30 |
Kyorin Seiyaku Kk |
Derivados de sulfuro de diarilo, sales de los mismos y agentes inmunosupresores que utilizan los mismos.
|
WO2003032989A1
(fr)
|
2001-10-18 |
2003-04-24 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Composes d'uree benzo fusionnes 1,4-disubstitues utilises comme inhibiteurs des cytokines
|
GB0229931D0
(en)
|
2002-12-21 |
2003-01-29 |
Astrazeneca Ab |
Therapeutic agents
|
SE0104334D0
(sv)
|
2001-12-19 |
2001-12-19 |
Astrazeneca Ab |
Therapeutic agents
|
AU2002351752A1
(en)
|
2001-12-29 |
2003-07-30 |
Novo Nordisk A/S |
Combined use of a glp-1 compound and another drug for treating dyslipidemia
|
WO2003057689A1
(fr)
|
2002-01-02 |
2003-07-17 |
Fujisawa Pharmaceutical Co., Ltd. |
Composes aminopyrimidine, procedes de preparation de ces composes et compositions pharmaceutiques les contenant
|
US20070225351A1
(en)
|
2002-01-11 |
2007-09-27 |
Lippa Arnold S |
Methods and compositions for controlling body weight and appetite
|
CA2473441A1
(fr)
|
2002-01-18 |
2003-07-24 |
The Genetics Company Inc. |
Inhibiteurs de beta-secretase
|
US20050070506A1
(en)
|
2002-01-18 |
2005-03-31 |
Doherty George A. |
Selective s1p1/edg1 receptor agonists
|
ATE441654T1
(de)
|
2002-01-18 |
2009-09-15 |
Merck & Co Inc |
Edg-rezeptoragonisten
|
GB0201850D0
(en)
|
2002-01-26 |
2002-03-13 |
Astrazeneca Ab |
Therapeutic treatment
|
EP1482896A4
(fr)
|
2002-03-01 |
2005-11-23 |
Merck & Co Inc |
Aminoalkylphosphonates et composes associes utilises en tant qu'agonistes du recepteur edg
|
CA2477423A1
(fr)
|
2002-03-01 |
2003-09-12 |
Merck & Co., Inc. |
Aminoalkylphosphonates et composes associes utilises en tant qu'agonistes du recepteur edg
|
WO2003076418A1
(fr)
|
2002-03-07 |
2003-09-18 |
X-Ceptor Therapeutics, Inc. |
Modulateurs des quinazolinones des recepteurs nucleaires
|
JP2005520821A
(ja)
|
2002-03-15 |
2005-07-14 |
チバ スペシャルティ ケミカルズ ホールディング インコーポレーテッド |
4−アミノピリミジン及び表面の抗菌処理のためのその使用
|
PE20040291A1
(es)
|
2002-03-22 |
2004-07-02 |
Novartis Ag |
COMBINACION QUE COMPRENDE UN INHIBIDOR DE HMG-CoA-REDUCTASA Y UN POTENCIADOR DE LA SECRECION DE INSULINA Y/O UN SENSIBILIZANTE DE INSULINA
|
WO2003088962A1
(fr)
|
2002-04-16 |
2003-10-30 |
Merck & Co., Inc. |
Therapie combinatoire faisant appel a un agoniste de ppar alpha/gamma
|
AU2003222786A1
(en)
|
2002-04-18 |
2003-10-27 |
Ucb, S.A. |
Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions
|
DE10219435A1
(de)
|
2002-05-02 |
2003-11-13 |
Bayer Cropscience Ag |
Substituierte Pyrazolo-pyrimidin-4-one
|
AU2003225305A1
(en)
|
2002-05-08 |
2003-11-11 |
Bristol-Myers Squibb Company |
Pyridine-based thyroid receptor ligands
|
US7057046B2
(en)
|
2002-05-20 |
2006-06-06 |
Bristol-Myers Squibb Company |
Lactam glycogen phosphorylase inhibitors and method of use
|
WO2003103640A1
(fr)
|
2002-06-10 |
2003-12-18 |
Elan Pharma International, Ltd |
Formulations nanoparticulaires comprenant des derives d'un inhibiteur de la hmg coa-reductase (≤statines≥), nouvelles combinaisons associees et production de ces compositions pharmaceutiques
|
AU2003241478A1
(en)
|
2002-06-10 |
2003-12-22 |
Elan Pharma International, Ltd. |
Nanoparticulate sterol formulations and sterol combinations
|
AR040241A1
(es)
|
2002-06-10 |
2005-03-23 |
Merck & Co Inc |
Inhibidores de la 11-beta-hidroxiesteroide deshidrogrenasa 1 para el tratamiento de la diabetes obesidad y dislipidemia
|
WO2003103632A1
(fr)
|
2002-06-10 |
2003-12-18 |
Elan Pharma International, Ltd. |
Formulation de polycosanol nanoparticulaires et nouvelles combinaisons de polycosanol
|
WO2003105763A2
(fr)
|
2002-06-14 |
2003-12-24 |
Amylin Pharmaceuticals, Inc. |
Prevention et/ou traitement de maladie enterique inflammatoire au moyen de peptides yy ou d'antagonistes de peptides yy
|
DE10226943A1
(de)
|
2002-06-17 |
2004-01-08 |
Bayer Ag |
Phenylaminopyrimidine und ihre Verwendung
|
WO2003105771A2
(fr)
|
2002-06-17 |
2003-12-24 |
Merck & Co., Inc. |
1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates et 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates utilises en tant qu'agonistes du recepteur edg
|
GB0214254D0
(en)
|
2002-06-20 |
2002-07-31 |
Glaxo Group Ltd |
Chemical compounds
|
SE0201976D0
(sv)
|
2002-06-24 |
2002-06-24 |
Astrazeneca Ab |
Novel compounds
|
SE0201980D0
(sv)
|
2002-06-24 |
2002-06-24 |
Astrazeneca Ab |
Novel compounds
|
US20060014717A1
(en)
|
2002-06-28 |
2006-01-19 |
Glykos Finland Oy |
Therapeutic compositions for use in prophylaxis or treatment of diarrheas
|
US20040053842A1
(en)
|
2002-07-02 |
2004-03-18 |
Pfizer Inc. |
Methods of treatment with CETP inhibitors and antihypertensive agents
|
US7071210B2
(en)
|
2002-07-02 |
2006-07-04 |
Pfizer Inc. |
CETP inhibitors in combination with antihypertensive agents and uses thereof
|
EP1541563A4
(fr)
|
2002-07-10 |
2007-11-07 |
Ono Pharmaceutical Co |
Antagoniste du ccr4 et utilisation medicinale correspondante
|
EP1551841A1
(fr)
|
2002-07-23 |
2005-07-13 |
SmithKline Beecham Corporation |
Inhibiteurs de kinase sous forme de pyrazolopyrimidines
|
US20050267133A1
(en)
|
2002-07-23 |
2005-12-01 |
Brown Matthew L |
Pyrazolopyrimidines as kinase inhibitors
|
US20060167020A1
(en)
|
2002-07-23 |
2006-07-27 |
Dickerson Scott H |
Pyrazolopyrimidines as kinase inhibitors
|
US20060105445A1
(en)
|
2002-07-29 |
2006-05-18 |
Klaus Godl |
Medium and method for enriching, purifying or depleting atp binding proteins from a pool of proteins
|
WO2004010949A2
(fr)
|
2002-07-30 |
2004-02-05 |
University Of Virginia Patent Foundation |
Composes actifs dans la signalisation de sphingosine 1-phosphate
|
EP1539136B1
(fr)
|
2002-07-30 |
2008-07-09 |
Merck & Co., Inc. |
Composes selectifs des recepteurs ppar alpha destines au traitement de la dyslipidemie et d'autres troubles lipidiques
|
DE60332738D1
(de)
|
2002-07-30 |
2010-07-08 |
Merck Sharp & Dohme |
Ppar alpha selektive verbindungen zur behandlung von dyslipidämie und anderen lipidstörungen
|
NZ537952A
(en)
|
2002-08-08 |
2008-04-30 |
Amgen Inc |
Vanilloid receptor ligands and their use in treatments
|
DE10237722A1
(de)
|
2002-08-17 |
2004-08-19 |
Aventis Pharma Deutschland Gmbh |
Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase
|
JP2006500378A
(ja)
|
2002-08-21 |
2006-01-05 |
メルク エンド カムパニー インコーポレーテッド |
二元PPARα/γアゴニストとアンギオテンシンIIのI型受容体アンタゴニストを使用する併用療法
|
DE60332125D1
(de)
|
2002-08-29 |
2010-05-27 |
Merck Sharp & Dohme |
Indole mit antidiabetischer wirkung
|
JP4340232B2
(ja)
|
2002-08-29 |
2009-10-07 |
メルク エンド カムパニー インコーポレーテッド |
抗糖尿病活性を有するインドール類
|
CA2489405A1
(fr)
|
2002-09-11 |
2004-03-25 |
Yamanouchi Pharmaceutical Co., Ltd. |
Procede de criblage d'un agent pour accroitre la teneur en insuline
|
AU2003275242B2
(en)
|
2002-09-27 |
2010-03-04 |
Merck Sharp & Dohme Corp. |
Substituted pyrimidines
|
US7067658B2
(en)
|
2002-09-30 |
2006-06-27 |
Bristol-Myers Squibb Company |
Pyridino and pyrimidino pyrazinones
|
AU2003282679A1
(en)
|
2002-10-04 |
2004-05-04 |
Arena Pharmaceuticals, Inc. |
Hydroxypyrazoles for use against metabolic-related disorders
|
AU2003284111A1
(en)
|
2002-10-09 |
2004-05-04 |
Genaissance Pharmaceuticals, Inc. |
Itgb3 gene haplotypes and atorvastatin dose effects on hdl cholesterol
|
JP2006504755A
(ja)
|
2002-10-15 |
2006-02-09 |
スミスクライン ビーチャム コーポレーション |
Gsk−3阻害薬としてのピリダジン化合物
|
US7129239B2
(en)
|
2002-10-28 |
2006-10-31 |
Pfizer Inc. |
Purine compounds and uses thereof
|
CA2503715A1
(fr)
|
2002-10-30 |
2004-05-21 |
Merck & Co., Inc. |
Inhibiteurs de kinase
|
WO2004041266A1
(fr)
|
2002-11-08 |
2004-05-21 |
Takeda Pharmaceutical Company Limited |
Agent de controle de la fonction recepteur
|
US7098235B2
(en)
|
2002-11-14 |
2006-08-29 |
Bristol-Myers Squibb Co. |
Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds
|
US20040110241A1
(en)
|
2002-12-06 |
2004-06-10 |
Segal Mark S. |
Materials and methods for monitoring vascular endothelial function
|
AU2003299791A1
(en)
|
2002-12-20 |
2004-07-22 |
Bayer Pharmaceuticals Corporation |
Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
|
DE60335827D1
(de)
|
2002-12-20 |
2011-03-03 |
Merck Sharp & Dohme |
1-(amino)indane als edg-rezeptoragonisten
|
JO2397B1
(en)
|
2002-12-20 |
2007-06-17 |
ميرك شارب اند دوم كوربوريشن |
Terazol derivatives as beta-hydroxy steroid dihydrogenase-1 inhibitors
|
EP1578715B1
(fr)
|
2002-12-20 |
2011-03-02 |
Bayer Pharmaceuticals Corporation |
Derives d'acide acetique d'indane et leur utilisation en tant qu'agents pharmaceutiques et intermediaires, et procede de preparation correspondant
|
GB0230020D0
(en)
|
2002-12-23 |
2003-01-29 |
Syngenta Ltd |
Fungicides
|
GB0230021D0
(en)
|
2002-12-23 |
2003-01-29 |
Syngenta Ltd |
Fungicides
|
DK1599468T3
(da)
|
2003-01-14 |
2008-02-04 |
Arena Pharm Inc |
1,2,3-trisubstituerede aryl- og heteroarylderivater som modulatorer af metabolisme og forebyggelse og behandling af forstyrrelser forbundet dermed såsom diabetes og hyperglykæmi
|
JP2006515334A
(ja)
|
2003-01-16 |
2006-05-25 |
エスビー ファームコ プエルト リコ インコーポレーテッド |
CRF受容体アンタゴニストとしてのヘテロアリール置換ピロロ[2,3−b]ピリジン誘導体
|
JP2007504285A
(ja)
|
2003-01-17 |
2007-03-01 |
メルク エンド カムパニー インコーポレーテッド |
N−シクロヘキシルアミノカルボニルベンゼンスルホンアミド誘導体
|
GB0301259D0
(en)
|
2003-01-20 |
2003-02-19 |
Novartis Ag |
Organic compounds
|
JP4505449B2
(ja)
|
2003-02-11 |
2010-07-21 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
新規二環式化合物および組成物
|
TW200418829A
(en)
|
2003-02-14 |
2004-10-01 |
Avanir Pharmaceutics |
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
|
EP2172472B1
(fr)
|
2003-02-18 |
2012-12-26 |
Kyorin Pharmaceutical Co., Ltd. |
Dérivé d'acide aminophosphonique et son sel d'addition et modulateur du récepteur S1P
|
DK1606282T3
(da)
|
2003-02-24 |
2009-03-16 |
Arena Pharm Inc |
Phenyl- og pyridylpipereidinye-derivater som modulatorer af glucosemetabolisme
|
EA200501376A1
(ru)
|
2003-03-28 |
2006-04-28 |
Пфайзер Продактс Инк. |
Производные 1,2,4-замещённых 1,2,3,4-тетрагидро- и 1,2-дигидрохинолинов и 1,2,3,4-тетрагидрохиноксалина в качестве ингибиторов сетр для лечения атеросклероза и тучности
|
AU2004236249A1
(en)
|
2003-04-30 |
2004-11-18 |
The Institutes Of Pharmaceutical Discovery, Llc |
Heterocycle substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1B
|
ATE547395T1
(de)
|
2003-04-30 |
2012-03-15 |
Novartis Pharma Gmbh |
Aminopropanol-derivate als modulatoren des sphingosin-1-phosphat-rezeptors
|
EP1622866B1
(fr)
|
2003-04-30 |
2012-07-25 |
Novartis AG |
Derives d'amino-propanol comme modulateurs de recepteur de sphingosine-1-phosphate
|
TWI393560B
(zh)
|
2003-05-02 |
2013-04-21 |
Japan Tobacco Inc |
包含s-〔2(〔〔1-(2-乙基丁基)環己基〕羰基〕胺基)苯基〕2-甲基丙烷硫酯及hmg輔酶a還原酶抑制劑之組合
|
SE0301368D0
(sv)
|
2003-05-09 |
2003-05-09 |
Astrazeneca Ab |
Chemical compounds
|
US7083933B1
(en)
|
2003-05-09 |
2006-08-01 |
Prosidion Limited |
Methods for identification of modulators of OSGPR116 activity
|
EP1625123A4
(fr)
|
2003-05-15 |
2007-08-29 |
Merck & Co Inc |
3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles servant d'agonistes du recepteur s1p
|
WO2004104205A2
(fr)
|
2003-05-16 |
2004-12-02 |
Merck & Co., Inc. |
Preparation enzymatique d'esters d'indole chiraux
|
MY150088A
(en)
|
2003-05-19 |
2013-11-29 |
Irm Llc |
Immunosuppressant compounds and compositions
|
JP4944613B2
(ja)
|
2003-05-19 |
2012-06-06 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
免疫抑制化合物および組成物
|
BRPI0410746A
(pt)
|
2003-05-19 |
2006-06-27 |
Irm Llc |
compostos e composições imunossupressoras
|
DK1638551T3
(da)
|
2003-05-19 |
2012-04-02 |
Irm Llc |
Immunosuppressive forbindelser og sammensætninger
|
US6987118B2
(en)
|
2003-05-21 |
2006-01-17 |
Pfizer Inc. |
Tetrahydroisoquinoline derivatives as PPAR-alpha activators
|
WO2004110368A2
(fr)
|
2003-06-06 |
2004-12-23 |
Merck & Co., Inc. |
Polytherapie pour le traitement de l'hypertension
|
AU2003902882A0
(en)
|
2003-06-10 |
2003-06-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Piperidyl derivatives
|
GB0313612D0
(en)
|
2003-06-12 |
2003-07-16 |
Novartis Ag |
Organic compounds
|
AR045047A1
(es)
|
2003-07-11 |
2005-10-12 |
Arena Pharm Inc |
Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
|
EP2287166A3
(fr)
|
2003-07-14 |
2011-06-22 |
Arena Pharmaceuticals, Inc. |
Dérivés d'hétéroaryle et aryle fusionné en tant que modulateurs du métabolisme et prophylaxie et traitement des troubles associés
|
EP1661879A4
(fr)
|
2003-08-04 |
2006-11-29 |
Ono Pharmaceutical Co |
Compose d'ether de diphenyle, sa methode de preparation et d'utilisation
|
CA2533320A1
(fr)
|
2003-08-15 |
2006-02-24 |
Novartis Ag |
2, 4-pyrimidine diamines utiles dans le cadre du traitement de maladies neoplasiques, de troubles inflammatoires et de troubles du systeme immunitaire
|
US7528120B2
(en)
|
2003-08-28 |
2009-05-05 |
Novartis Ag |
Aminopropanol derivatives
|
MXPA06002310A
(es)
|
2003-08-29 |
2006-05-25 |
Ono Pharmaceutical Co |
Compuesto capaz de enlazarse al receptor s1p y uso farmaceutico del mismo.
|
CN101407471A
(zh)
|
2003-08-29 |
2009-04-15 |
小野药品工业株式会社 |
能够结合s1p受体的化合物及其药物用途
|
CA2536251C
(fr)
|
2003-09-02 |
2009-08-04 |
Merck & Co., Inc. |
Nouvelles formes cristallines d'un sel d'acide phosphorique d'un inhibiteur de dipeptidyl peptidase-iv
|
WO2005023762A1
(fr)
|
2003-09-04 |
2005-03-17 |
Abbott Laboratories |
Derives de pyrrolidine-2-carbonitrile et leur utilisation comme inhibiteurs de la dipeptidyle peptidase-iv (dpp-iv)
|
TW201127828A
(en)
|
2003-09-05 |
2011-08-16 |
Vertex Pharma |
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
|
US7732442B2
(en)
|
2003-09-05 |
2010-06-08 |
Ono Pharmaceutical Co., Ltd. |
Chemokine receptor antagonist and medical use thereof
|
WO2005030751A2
(fr)
|
2003-09-08 |
2005-04-07 |
Takeda Pharmaceutical Company Limited |
Inhibiteurs de dipeptidyle peptidase
|
EP1699777B1
(fr)
|
2003-09-08 |
2012-12-12 |
Takeda Pharmaceutical Company Limited |
Inhibiteurs de la dipeptidylpeptidase
|
WO2005025554A2
(fr)
|
2003-09-09 |
2005-03-24 |
Japan Tobacco Inc. |
Inhibiteur de la dipeptidylpeptidase iv
|
AU2004275719B2
(en)
|
2003-09-23 |
2010-08-19 |
Merck Sharp & Dohme Corp. |
Quinoline potassium channel inhibitors
|
EP1667524A4
(fr)
|
2003-09-23 |
2009-01-14 |
Merck & Co Inc |
Nouvelle forme cristalline d'un sel d'acide phosphorique d'un inhibiteur de dipeptidyle peptase-iv
|
AU2004277947A1
(en)
|
2003-10-01 |
2005-04-14 |
Merck & Co., Inc. |
3,5-aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as S1P receptor agonists
|
WO2005033099A2
(fr)
|
2003-10-03 |
2005-04-14 |
Glenmark Pharmaceuticals Ltd. |
Nouveaux inhibiteurs de dipeptidylpeptidase iv, leurs procedes de preparation et compositions les contenant
|
WO2005037215A2
(fr)
|
2003-10-14 |
2005-04-28 |
Massachusetts Institute Of Technology |
Compositions et procedes destines a ameliorer la fonction cognitive et la plasticite synaptique
|
GB0324236D0
(en)
|
2003-10-16 |
2003-11-19 |
Astrazeneca Ab |
Chemical compounds
|
PE20050444A1
(es)
|
2003-10-31 |
2005-08-09 |
Takeda Pharmaceutical |
Compuestos de piridina como inhibidores de la peptidasa
|
US7638637B2
(en)
|
2003-11-03 |
2009-12-29 |
University Of Virginia Patent Foundation |
Orally available sphingosine 1-phosphate receptor agonists and antagonists
|
JPWO2005044780A1
(ja)
|
2003-11-10 |
2007-05-17 |
杏林製薬株式会社 |
アミノカルボン酸誘導体とその付加塩及びs1p受容体調節剤
|
WO2005046603A2
(fr)
|
2003-11-10 |
2005-05-26 |
Synta Pharmaceuticals, Corp. |
Composes pyridiniques
|
WO2005047297A1
(fr)
|
2003-11-12 |
2005-05-26 |
Phenomix Corporation |
Composés heterocycliques d'acide boronique
|
MY141220A
(en)
|
2003-11-17 |
2010-03-31 |
Astrazeneca Ab |
Pyrazole derivatives as inhibitors of receptor tyrosine kinases
|
WO2005058315A1
(fr)
|
2003-12-12 |
2005-06-30 |
Ribapharm, Inc. |
Nouveaux composes heterocycliques utilises comme inhibiteurs et presentant une activite anti-hbv
|
WO2005058849A1
(fr)
|
2003-12-15 |
2005-06-30 |
Glenmark Pharmaceuticals Ltd. |
Nouveaux inhibiteurs de dipeptidyle peptidase iv, leur procede de preparation et compositions les contenant
|
CA2547198A1
(fr)
|
2003-12-17 |
2005-06-30 |
Merck & Co., Inc. |
Carboxylates propanoiques 3,4-disusbstitues utilises en tant qu'agonistes du recepteur s1p (edg)
|
GB0329498D0
(en)
|
2003-12-19 |
2004-01-28 |
Novartis Ag |
Organic compounds
|
WO2005058790A1
(fr)
|
2003-12-19 |
2005-06-30 |
Ono Pharmaceutical Co., Ltd. |
Composes antagonistes des recepteurs a l'acide lysophosphatidique et leurs utilisations
|
DE10360835A1
(de)
|
2003-12-23 |
2005-07-21 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Bicyclische Imidazolverbindungen, deren Herstellung und deren Verwendung als Arzneimittel
|
NZ547965A
(en)
|
2003-12-24 |
2009-12-24 |
Prosidion Ltd |
1,2,4-Oxadiazole derivatives as GPCR receptor agonists
|
US20080227786A1
(en)
|
2004-01-16 |
2008-09-18 |
Ferlita Russell R |
Novel Crystalline Salts of a Dipeptidyl Peptidase-IV Inhibitor
|
GB0401332D0
(en)
|
2004-01-21 |
2004-02-25 |
Novartis Ag |
Organic compounds
|
WO2005075426A1
(fr)
|
2004-02-03 |
2005-08-18 |
Glenmark Pharmaceuticals Ltd. |
Nouveaux inhibiteurs de dipeptidyle peptidase iv, leur procedes de preparation et compositions en comportant
|
EP1745034A1
(fr)
|
2004-02-11 |
2007-01-24 |
Amgen Inc. |
Ligands du recepteur vanilloide et leurs applications dans des traitements
|
TW200530236A
(en)
|
2004-02-23 |
2005-09-16 |
Chugai Pharmaceutical Co Ltd |
Heteroaryl phenylurea
|
KR20110136901A
(ko)
|
2004-02-24 |
2011-12-21 |
상꾜 가부시키가이샤 |
아미노 알코올 화합물
|
TW200538433A
(en)
|
2004-02-24 |
2005-12-01 |
Irm Llc |
Immunosuppressant compounds and compositiions
|
AU2005217641B2
(en)
|
2004-02-24 |
2008-02-14 |
Irm Llc |
Immunosuppressant compounds and compositions
|
US7902369B2
(en)
|
2004-03-05 |
2011-03-08 |
Banyu Pharmaceutical Co., Ltd. |
Diaryl-substituted five-membered heterocycle derivative
|
GB0405289D0
(en)
|
2004-03-09 |
2004-04-21 |
Novartis Ag |
Organic compounds
|
GB0405933D0
(en)
|
2004-03-16 |
2004-04-21 |
Glaxo Group Ltd |
Compounds
|
EP1737820B1
(fr)
|
2004-04-02 |
2008-01-16 |
Merck & Co., Inc. |
Procede d'hydrogenation asymetrique utile pour la preparation de derives de cycloalcanoindole
|
US20070219234A1
(en)
|
2004-04-12 |
2007-09-20 |
Kiyoshi Oizumi |
Thienopyridine Derivatives
|
EP1750727A2
(fr)
|
2004-04-23 |
2007-02-14 |
Exelixis, Inc. |
Modulateurs des proteines kinases et leurs methodes d'utilisation
|
WO2005121121A2
(fr)
|
2004-06-04 |
2005-12-22 |
Arena Pharmaceuticals, Inc. |
Derives d'aryle et d'heteroaryle substitues tenant lieu de modulateurs du metabolisme et prevention et traitement de troubles associes
|
WO2005123677A1
(fr)
|
2004-06-16 |
2005-12-29 |
Actelion Pharmaceuticals Ltd |
Utilisation de derives de 1,1,2-trimethyl-1a,4,5,5a-tetrahydro-1h-4-aza-cyclopropa[a]pentalene a substitution 4-carbonyle comme agonistes du recepteur couple aux proteines g s1p1/edg1 et agents immunosuppresseurs
|
JP5315611B2
(ja)
|
2004-06-23 |
2013-10-16 |
小野薬品工業株式会社 |
S1p受容体結合能を有する化合物およびその用途
|
MX2007000564A
(es)
|
2004-07-16 |
2007-03-30 |
Kyorin Seiyaku Kk |
Metodo para utilizar efectivamente medicamentos referentes a la prevencion de efectos secundarios.
|
JP2007284350A
(ja)
|
2004-07-27 |
2007-11-01 |
Takeda Chem Ind Ltd |
糖尿病治療剤
|
TW200611687A
(en)
|
2004-07-29 |
2006-04-16 |
Sankyo Co |
Pharmaceutical compositions used for immunosuppressant
|
WO2006010379A1
(fr)
|
2004-07-29 |
2006-02-02 |
Actelion Pharmaceuticals Ltd. |
Nouveaux derives du thiophene utilises comme agents immunosupresseurs
|
EP1798226A4
(fr)
|
2004-08-04 |
2009-06-17 |
Taisho Pharmaceutical Co Ltd |
Derive de traizol
|
EP1781595A1
(fr)
|
2004-08-13 |
2007-05-09 |
Praecis Pharmaceuticals Inc. |
Procedes et compositions servant a moduler l'activite du recepteur de la sphingosine-1-phosphate (s1p)
|
US20060223866A1
(en)
|
2004-08-13 |
2006-10-05 |
Praecis Pharmaceuticals, Inc. |
Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity
|
ATE494895T1
(de)
|
2004-09-20 |
2011-01-15 |
Xenon Pharmaceuticals Inc |
Pyridin-derivate zur hemmung der menschlichen stearoyl-coa-desaturase
|
MX2007003371A
(es)
|
2004-09-23 |
2007-05-07 |
Wyeth Corp |
Derivados de carbazol y ciclopentaindol para tratar infeccion con virus de hepatitis c.
|
JP4797021B2
(ja)
|
2004-10-01 |
2011-10-19 |
メルク・シャープ・エンド・ドーム・コーポレイション |
糖尿病の治療または予防用のジペプチジルペプチダ−ゼ−iv阻害剤としてのアミノピペリジン
|
JP4862654B2
(ja)
|
2004-10-08 |
2012-01-25 |
アステラス製薬株式会社 |
芳香環縮合ピリミジン誘導体
|
BRPI0515992A
(pt)
|
2004-10-12 |
2008-08-19 |
Forbes Medi Tech Res Inc |
compostos e métodos para o tratamento de resistência à insulina e cardiomiopatia
|
TW200621257A
(en)
|
2004-10-20 |
2006-07-01 |
Astellas Pharma Inc |
Pyrimidine derivative fused with nonaromatic ring
|
CA2583681A1
(fr)
|
2004-10-22 |
2006-05-04 |
Merck & Co., Inc. |
Carboxylates, sulfonates, phosphonates, phosphinates 2-(aryl)azacyclylmethyle et heterocycles utilises comme agonistes des recepteurs s1p
|
PL1650186T3
(pl)
|
2004-10-22 |
2008-11-28 |
Bioprojet Soc Civ |
Nowe pochodne kwasów dikarboksylowych
|
AR051596A1
(es)
|
2004-10-26 |
2007-01-24 |
Irm Llc |
Compuestos heterociclicos condensados nitrogenados como inhibidores de la actividad del receptor canabinoide 1; composiciones farmaceuticas que los contienen y su empleo en la preparacion de medicamentos para el tratamiento de trastornos alimentarios
|
US20080312277A1
(en)
|
2004-11-03 |
2008-12-18 |
Leonard James N |
Gpr41 and Modulators Thereof for the Treatment of Insulin-Related Disorders
|
GB0425035D0
(en)
|
2004-11-12 |
2004-12-15 |
Novartis Ag |
Organic compounds
|
JP2008520692A
(ja)
|
2004-11-18 |
2008-06-19 |
ジ インスチチュート フォー ファーマシューティカル ディスカバリー、エルエルシー |
複素環置換カルボン酸
|
WO2006057448A1
(fr)
|
2004-11-26 |
2006-06-01 |
Takeda Pharmaceutical Company Limited |
Dérivé d’acide arylalcanoïque
|
EP1827606A2
(fr)
|
2004-12-06 |
2007-09-05 |
University Of Virginia Patent Foundation |
Analogues d'aryl amide sphingosine 1-phosphate
|
ES2378776T3
(es)
|
2004-12-13 |
2012-04-17 |
Ono Pharmaceutical Co., Ltd. |
Derivado de ácido aminocarboxílico y uso medicinal del mismo
|
BRPI0519006A2
(pt)
|
2004-12-13 |
2008-12-23 |
Daiichi Sankyo Co Ltd |
uso de um inibidor de fbpase, kit de uma composiÇço farmacÊutica, uso de uma preparaÇço de biguanida e um inibidor de fbpase, agente terapÊutico para diabetes melito, e, combinaÇço de agentes terapÊuticos
|
US20080312281A1
(en)
|
2004-12-24 |
2008-12-18 |
Matthew Colin Thor Fyfe |
G-Protein Coupled Receptor (Gpr116) Agonists and Use Thereof for Treating Obesity and Diabetes
|
EP1838706A1
(fr)
|
2004-12-24 |
2007-10-03 |
Prosidion Limited |
Agonistes du récepteur couplé aux protéines g
|
GB0428514D0
(en)
|
2004-12-31 |
2005-02-09 |
Prosidion Ltd |
Compounds
|
DOP2006000010A
(es)
|
2005-01-10 |
2006-07-31 |
Arena Pharm Inc |
Procedimiento para preparar eteres aromáticos
|
DOP2006000008A
(es)
|
2005-01-10 |
2006-08-31 |
Arena Pharm Inc |
Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
|
MY148521A
(en)
|
2005-01-10 |
2013-04-30 |
Arena Pharm Inc |
Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
|
DOP2006000009A
(es)
|
2005-01-13 |
2006-08-15 |
Arena Pharm Inc |
Procedimiento para preparar eteres de pirazolo [3,4-d] pirimidina
|
CN101107245A
(zh)
|
2005-01-19 |
2008-01-16 |
神经能质公司 |
经杂芳基取代的哌嗪-吡啶类似物
|
JP5798282B2
(ja)
|
2005-01-25 |
2015-10-21 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
メソゲン性化合物、液晶媒体および液晶ディスプレイ
|
EP1685841A1
(fr)
|
2005-01-31 |
2006-08-02 |
Bayer Health Care Aktiengesellschaft |
Prevention et traitement de troubles thromboemboliques
|
US7754703B2
(en)
|
2005-02-14 |
2010-07-13 |
University Of Virginia Patent Foundation |
Cycloalkane-containing sphingosine 1-phosphate agonists
|
US7605269B2
(en)
|
2005-03-23 |
2009-10-20 |
Actelion Pharmaceuticals Ltd. |
Thiophene derivatives as Sphingosine-1-phosphate-1 receptor agonists
|
EP1863475B1
(fr)
|
2005-03-23 |
2011-09-07 |
Actelion Pharmaceuticals Ltd. |
Nouveaux derives de thiophene en tant qu´agonistes du recepteur de sphingosine-1-phosphate-1
|
ES2365747T3
(es)
|
2005-03-23 |
2011-10-10 |
Actelion Pharmaceuticals Ltd. |
Derivados de benzo[c]tiofeno hidrogenados como inmunomoduladores.
|
WO2006131336A1
(fr)
|
2005-06-08 |
2006-12-14 |
Novartis Ag |
Oxadiazoles polycycliques ou soxazoles i et leur utilisation comme ligands recepteurs de s1p
|
TWI418350B
(zh)
|
2005-06-24 |
2013-12-11 |
Sankyo Co |
含有ppar調節劑之醫藥組成物的用途
|
AU2006260573A1
(en)
|
2005-06-24 |
2006-12-28 |
Actelion Pharmaceuticals Ltd. |
Novel thiophene derivatives
|
EP1909791A1
(fr)
|
2005-06-30 |
2008-04-16 |
Prosidion Limited |
Agonistes du récepteur couplé aux protéines g
|
BRPI0613501A2
(pt)
|
2005-07-01 |
2011-01-11 |
Irm Llc |
composto, composição farmacêutica e uso do mesmo
|
US20070060573A1
(en)
|
2005-08-10 |
2007-03-15 |
Lars Wortmann |
Acyltryptophanols
|
AU2006283175A1
(en)
|
2005-08-23 |
2007-03-01 |
Irm Llc |
Immunosuppressant compounds and compositions
|
KR20080044296A
(ko)
|
2005-09-16 |
2008-05-20 |
아레나 파마슈티칼스, 인크. |
대사 조절제 및 이와 관련된 장애의 치료
|
TW200745055A
(en)
|
2005-09-23 |
2007-12-16 |
Organon Nv |
4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives
|
JPWO2007037196A1
(ja)
|
2005-09-29 |
2009-04-09 |
山本化成株式会社 |
インドリン系化合物及びその製造方法
|
WO2007043433A1
(fr)
*
|
2005-10-07 |
2007-04-19 |
Kyorin Pharmaceutical Co., Ltd. |
Agent therapeutique destine a une maladie du foie contenant un derive 2-amino-1,3-propanediol servant de principe actif, et methode therapeutique associee destinee a une maladie hepatique
|
AR057894A1
(es)
|
2005-11-23 |
2007-12-26 |
Actelion Pharmaceuticals Ltd |
Derivados de tiofeno
|
WO2007061458A2
(fr)
|
2005-11-23 |
2007-05-31 |
Epix Delaware, Inc. |
Composes modulateurs du recepteur s1p et utilisation associee
|
CN103265495B
(zh)
|
2005-12-29 |
2016-11-16 |
莱西肯医药有限公司 |
多环氨基酸衍生物及其使用方法
|
TWI404706B
(zh)
|
2006-01-11 |
2013-08-11 |
Actelion Pharmaceuticals Ltd |
新穎噻吩衍生物
|
TW200736234A
(en)
|
2006-01-17 |
2007-10-01 |
Astrazeneca Ab |
Chemical compounds
|
ES2600804T3
(es)
|
2006-01-19 |
2017-02-10 |
Orchid Pharma Limited |
Nuevos heterociclos
|
WO2007086001A2
(fr)
|
2006-01-24 |
2007-08-02 |
Actelion Pharmaceuticals Ltd |
Nouveaux dérivés de pyridine
|
GB0601744D0
(en)
|
2006-01-27 |
2006-03-08 |
Novartis Ag |
Organic compounds
|
TWI389683B
(zh)
|
2006-02-06 |
2013-03-21 |
Kyorin Seiyaku Kk |
A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient
|
TW200806611A
(en)
|
2006-02-09 |
2008-02-01 |
Daiichi Seiyaku Co |
Novel amidopropionic acid derivatives and medicine containing the same
|
WO2007092638A1
(fr)
|
2006-02-09 |
2007-08-16 |
University Of Virginia Patent Foundation |
Analogues de sphingosine 1-phosphate bicyclique
|
US20070191371A1
(en)
|
2006-02-14 |
2007-08-16 |
Kalypsys, Inc. |
Heterocyclic modulators of ppar
|
CN101460458A
(zh)
|
2006-02-15 |
2009-06-17 |
阿勒根公司 |
具有1-磷酸-鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚-3-羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物
|
AU2007214434B2
(en)
|
2006-02-15 |
2012-06-14 |
Allergan, Inc. |
Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
|
AU2007217006A1
(en)
|
2006-02-21 |
2007-08-30 |
University Of Virginia Patent Foundation |
Phenyl-cycloalkyl and phenyl-heterocyclic derivatives as SIP receptor agonists
|
US7649098B2
(en)
|
2006-02-24 |
2010-01-19 |
Lexicon Pharmaceuticals, Inc. |
Imidazole-based compounds, compositions comprising them and methods of their use
|
WO2007106469A2
(fr)
|
2006-03-14 |
2007-09-20 |
Amgen Inc. |
Derives bicycliques de l'acide carboxylique utiles dans le traitement de troubles metaboliques
|
US7790707B2
(en)
|
2006-03-21 |
2010-09-07 |
Epix Pharmaceuticals Inc. |
S1P receptor modulating compounds and use thereof
|
JP2007262009A
(ja)
|
2006-03-29 |
2007-10-11 |
Dai Ichi Seiyaku Co Ltd |
ヘテロアリール低級カルボン酸誘導体
|
MX2008012738A
(es)
|
2006-04-03 |
2009-02-06 |
Astellas Pharma Inc |
Heterocompuesto.
|
PE20071221A1
(es)
|
2006-04-11 |
2007-12-14 |
Arena Pharm Inc |
Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
|
WO2007120689A2
(fr)
|
2006-04-11 |
2007-10-25 |
Arena Pharmaceuticals, Inc. |
Procédés d'utilisation du récepteur gpr119 pour identifier des composés utiles pour augmenter la masse osseuse chez un individu
|
GB0607389D0
(en)
|
2006-04-12 |
2006-05-24 |
Novartis Ag |
Organic compounds
|
JPWO2007129745A1
(ja)
|
2006-05-09 |
2009-09-17 |
第一三共株式会社 |
ヘテロアリールアミド低級カルボン酸誘導体
|
WO2007132307A1
(fr)
|
2006-05-09 |
2007-11-22 |
Pfizer Products Inc. |
Dérivés d'acide cycloalkylaminé et compositions pharmaceutiques à base de ceux-ci
|
WO2007129473A1
(fr)
|
2006-05-09 |
2007-11-15 |
Daiichi Sankyo Company, Limited |
Dérivé arylique bicyclique
|
TW200811140A
(en)
|
2006-07-06 |
2008-03-01 |
Arena Pharm Inc |
Modulators of metabolism and the treatment of disorders related thereto
|
TW200811147A
(en)
|
2006-07-06 |
2008-03-01 |
Arena Pharm Inc |
Modulators of metabolism and the treatment of disorders related thereto
|
US8222261B2
(en)
|
2006-07-13 |
2012-07-17 |
GlaxoSmithKline, LLC |
Chemical compounds
|
TW200823182A
(en)
|
2006-08-01 |
2008-06-01 |
Praecis Pharm Inc |
Chemical compounds
|
US20080070866A1
(en)
|
2006-08-01 |
2008-03-20 |
Praecis Pharmaceuticals Incorporated |
Chemical compounds
|
WO2008019090A2
(fr)
|
2006-08-04 |
2008-02-14 |
Praecis Pharmaceuticals Incorporated |
Composés chimiques
|
DK2058317T3
(da)
|
2006-08-08 |
2014-01-06 |
Kyorin Seiyaku Kk |
Aminophosphorsyreesterderivat og S1P receptormodulator indeholdende samme som aktiv ingrediens
|
JP2010501555A
(ja)
|
2006-08-24 |
2010-01-21 |
プリーシス・ファーマシューティカルズ・インコーポレイテッド |
S1p−1受容体アゴニスト
|
JP2009269819A
(ja)
|
2006-08-25 |
2009-11-19 |
Asahi Kasei Pharma Kk |
アミン化合物
|
EP2059516A1
(fr)
|
2006-08-30 |
2009-05-20 |
BIOVITRUM AB (publ) |
Composés de pyridine permettant de traiter les troubles liés à gpr119
|
BRPI0716815A2
(pt)
|
2006-09-07 |
2013-11-05 |
Allergan Inc |
Co posto heteroatomáticos tendo atividade biológia agonista e/ou antagonista de receptor de esfinfosina-1-fosfato (s1p)
|
TWI408139B
(zh)
|
2006-09-07 |
2013-09-11 |
Actelion Pharmaceuticals Ltd |
新穎噻吩衍生物
|
ES2400533T3
(es)
|
2006-09-07 |
2013-04-10 |
Actelion Pharmaceuticals Ltd. |
Derivados de piridin 4-ilo como agentes inmunomoduladores
|
AU2007293653B2
(en)
|
2006-09-08 |
2011-02-17 |
Novartis Ag |
N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions
|
US8044076B2
(en)
|
2006-09-21 |
2011-10-25 |
Actelion Pharmaceuticals Ltd. |
Phenyl derivatives and their use as immunomodulators
|
MX2009005935A
(es)
|
2006-12-06 |
2009-06-30 |
Smithkline Beecham Corp |
Compuestos biciclicos y su uso como anti-diabeticos.
|
CA2672059A1
(fr)
|
2006-12-14 |
2008-06-26 |
Merck & Co., Inc. |
Composes acyl-bipiperidinyle, compositions contenant de tels composes et procedes de traitement
|
US7834039B2
(en)
|
2006-12-15 |
2010-11-16 |
Abbott Laboratories |
Oxadiazole compounds
|
GB0625648D0
(en)
|
2006-12-21 |
2007-01-31 |
Glaxo Group Ltd |
Compounds
|
BRPI0720478A2
(pt)
|
2006-12-21 |
2014-01-14 |
Abbott Laboratoires |
Compostos agonistas e antagonistas do receptor esfingosina-1-fosfato
|
JO2701B1
(en)
|
2006-12-21 |
2013-03-03 |
جلاكسو جروب ليميتد |
Vehicles
|
EP2125723A1
(fr)
|
2007-01-11 |
2009-12-02 |
Allergan, Inc. |
Composé amide d'acide indole-3-carboxylique 6-substitué ayant une activité biologique d'antagoniste du récepteur de sphingosine-1-phosphate (s1p)
|
WO2008091967A1
(fr)
|
2007-01-26 |
2008-07-31 |
Smithkline Beecham Corporation |
Composés chimiques
|
WO2008097819A2
(fr)
|
2007-02-05 |
2008-08-14 |
Smithkline Beecham Corporation |
Composés chimiques
|
SI2125797T1
(sl)
|
2007-03-16 |
2014-03-31 |
Actelion Pharmaceuticals Ltd. |
Derivati amino-piridina kot agonisti receptorja s1p1/edg1
|
CA2679980A1
(fr)
|
2007-03-21 |
2007-09-27 |
Epix Pharmaceuticals, Inc. |
Composes modulant les recepteurs de la s1p et leur utilisation
|
WO2008128832A1
(fr)
|
2007-04-18 |
2008-10-30 |
Nicox S.A. |
Nitrodérivés non peptidiques d'inhibiteurs de la rénine destinés au traitement de maladies cardiovasculaires, rénales et chroniques du foie, des inflammations et du syndrome métabolique
|
JO2686B1
(en)
|
2007-04-19 |
2013-03-03 |
جلاكسو جروب ليمتد |
Vehicles
|
JP2010526145A
(ja)
|
2007-05-04 |
2010-07-29 |
ブリストル−マイヤーズ スクイブ カンパニー |
[6,6]および[6,7]−二環式gpr119gタンパク質結合受容体アゴニスト
|
EP2014653A1
(fr)
|
2007-06-15 |
2009-01-14 |
Bioprojet |
Nouveaux dérivés d'acide dicarboxylique comme agonistes du recepteur S1P1
|
WO2009011850A2
(fr)
|
2007-07-16 |
2009-01-22 |
Abbott Laboratories |
Nouveaux composés thérapeutiques
|
WO2009019506A1
(fr)
|
2007-08-03 |
2009-02-12 |
Astrazeneca Ab |
Sulfonamides hétérocycliques ayant une activité antagoniste de edg-1
|
MX2010001446A
(es)
|
2007-08-08 |
2010-03-01 |
Merck Serono Sa |
Derivados de 6-amino-pirimidina-4-carboxamida y compuestos relacionados que se enlazan a los receptores para esfingosina 1-fosfato (s1p) para el tratamiento de esclerosis multiple.
|
JP5465177B2
(ja)
|
2007-09-20 |
2014-04-09 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
Gpr119活性のモジュレーターとしての化合物および組成物
|
TW200930368A
(en)
|
2007-11-15 |
2009-07-16 |
Astrazeneca Ab |
Bis-(sulfonylamino) derivatives in therapy
|
EP2225201A2
(fr)
|
2007-11-28 |
2010-09-08 |
Synta Pharmaceuticals Corp. |
Polymorphes de n-malonyl-bis(n'-méthyl-n'-thiobenzoylhydrazide)
|
AU2008338965A1
(en)
|
2007-12-18 |
2009-06-25 |
Arena Pharmaceuticals, Inc. |
Tetrahydrocyclopenta[b]indol-3-yl carboxylic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
|
WO2009094157A1
(fr)
|
2008-01-25 |
2009-07-30 |
Arena Pharmaceuticals, Inc. |
Dérivés carboxyliques dihydro-1h-pyrrolo[1,2-a]indol-1-yle agissant comme des agonistes de s1p1
|
AR070398A1
(es)
|
2008-02-22 |
2010-03-31 |
Gruenenthal Chemie |
Derivados sustituidos de indol
|
WO2009108924A2
(fr)
|
2008-02-28 |
2009-09-03 |
Solar Roofing Systems, Inc. |
Tuile photovoltaïque avec matériau anti-incendie
|
AU2009227629B2
(en)
|
2008-03-17 |
2014-09-04 |
Actelion Pharmaceuticals Ltd |
Dosing regimen for a selective S1P1 receptor agonist
|
BRPI0911118A2
(pt)
|
2008-04-07 |
2015-10-06 |
Irm Llc |
composto e compisições como moduladores de atividade de gpr119
|
EP2146210A1
(fr)
|
2008-04-07 |
2010-01-20 |
Arena Pharmaceuticals, Inc. |
Procédés d'utilisation du récepteur couplé aux protéines A G pour identifier les secrétagogues de peptide YY (PYY) et composés utiles dans le traitement d'états modulés par PYY
|
WO2009125434A2
(fr)
|
2008-04-07 |
2009-10-15 |
Cadila Healthcare Limited |
Dérivés d’oxime
|
FI2291080T5
(fi)
|
2008-05-14 |
2023-11-06 |
The Scripps Research Institute |
Uusia sfingosiinifosfaattireseptorimodulaattoreita
|
WO2009151626A1
(fr)
|
2008-06-13 |
2009-12-17 |
Arena Pharmaceuticals, Inc. |
Dérivés de l’acide (1, 2, 4-oxadiazol-3-yl)indolin-1-yl carboxylique substitué pouvant être utilisés comme agonistes de s1p1
|
WO2009151621A1
(fr)
|
2008-06-13 |
2009-12-17 |
Arena Pharmaceuticals, Inc. |
Dérivés de l’acide (1, 2, 4-oxadiazol-3-yl)indolin-1-yl carboxylique substitué utiles comme agonistes de s1p1
|
KR20190132565A
(ko)
*
|
2008-07-23 |
2019-11-27 |
아레나 파마슈티칼스, 인크. |
자가면역성 및 염증성의 장애의 치료에 유용한 치환된 1,2,3,4-테트라히드로시클로펜타[b]인돌-3-일)아세트산 유도체
|
CN105816453B
(zh)
|
2008-08-27 |
2021-03-05 |
艾尼纳制药公司 |
用于治疗自身免疫性病症和炎性病症的作为s1p1受体激动剂的经取代的三环酸衍生物
|
UY32352A
(es)
|
2008-12-22 |
2010-07-30 |
Novartis Ag |
Régimen de dosificación para un agonista de los receptores de s1p
|
NZ593427A
(en)
|
2008-12-22 |
2013-11-29 |
Novartis Ag |
Dosage regimen of an s1p receptor agonist
|
WO2010075273A1
(fr)
|
2008-12-23 |
2010-07-01 |
Schering Corporation |
Dérivés d'hétérocycles bicycliques et leurs procédés d'utilisation
|
US8410122B2
(en)
|
2008-12-23 |
2013-04-02 |
Merck Sharp & Dohme Corp. |
Bicyclic heterocycle derivatives and methods of use thereof
|
WO2010074271A1
(fr)
|
2008-12-26 |
2010-07-01 |
武田薬品工業株式会社 |
Agent thérapeutique pour le diabète
|
EP2390254A1
(fr)
|
2009-01-22 |
2011-11-30 |
Mitsubishi Tanabe Pharma Corporation |
NOUVEAU COMPOSÉ PYRROLOÝ2,3-d¨PYRIMIDINE
|
US20100216762A1
(en)
|
2009-02-10 |
2010-08-26 |
Abbott Laboratories |
Agonists and Antagonists of the S1P5 Receptor, and Methods of Use Thereof
|
WO2011005290A1
(fr)
|
2009-06-23 |
2011-01-13 |
Arena Pharmaceuticals, Inc. |
Dérivés d'oxadiazole disubstitués utiles dans le traitement de troubles auto-immuns et inflammatoires
|
WO2011005295A1
(fr)
|
2009-06-24 |
2011-01-13 |
Arena Pharmaceuticals, Inc. |
Modulateurs du récepteur sphingosine-1-phosphate (s1p) utiles pour le traitement de troubles associés à ceux-ci
|
AR077642A1
(es)
|
2009-07-09 |
2011-09-14 |
Arena Pharm Inc |
Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo
|
AR077638A1
(es)
|
2009-07-15 |
2011-09-14 |
Lilly Co Eli |
Compuesto de (metanosulfonil -piperidin )-( alcoxi-aril) -tetrahidro- piridina , composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para el tratamiento de diabetes u obesidad
|
WO2011030139A1
(fr)
|
2009-09-11 |
2011-03-17 |
Astrazeneca Ab |
Derives de 4-(pyrimidin-2-yl)-piperazine et de 4-(pyrimidin-2-yl)-piperidine utilises en tant que modulateurs du gpr119
|
EP2493866A1
(fr)
|
2009-10-29 |
2012-09-05 |
Bristol-Myers Squibb Company |
Composés hétérocycliques tricycliques
|
US8299059B2
(en)
|
2009-10-30 |
2012-10-30 |
Eli Lilly And Company |
Crystalline compound and a process for its preparation
|
US8440693B2
(en)
|
2009-12-22 |
2013-05-14 |
Novartis Ag |
Substituted isoquinolinones and quinazolinones
|
MTP4285B
(en)
|
2009-12-30 |
2011-07-04 |
Medichem Sa |
A 1-(1h-1,2,3-triazol-1-yl)butan-2-ol derivative for pharmaceutical use, and the use of a 1-(1h-1, 2, 4- triazol-1yl) butan-2-ol derivative with substially undefined crystal shap for preparing said 1-(1h-1, 2, 4-triazol-1-yl0 butan-2-ol derivative
|
ES2937386T3
(es)
|
2010-01-27 |
2023-03-28 |
Arena Pharm Inc |
Procesos para la preparación de ácido (R)-2-(7-(4-ciclopentil-3-(trifluorometil)benciloxi)-1,2,3,4-tetrahidrociclopenta[b]indol-3-il)acético y sales del mismo
|
CA2789480A1
(fr)
|
2010-03-03 |
2011-09-09 |
Arena Pharmaceuticals, Inc. |
Procedes de synthese de modulateurs des recepteurs s1p1 et leurs formes cristallines
|
MX2012011631A
(es)
|
2010-04-06 |
2013-01-18 |
Arena Pharm Inc |
Moduladores del receptor gpr119 y el tratamiento de trastornos relacionados con el mismo.
|
US8747844B2
(en)
|
2010-07-30 |
2014-06-10 |
Saint Louis University |
Methods of treating pain
|
US10894787B2
(en)
|
2010-09-22 |
2021-01-19 |
Arena Pharmaceuticals, Inc. |
Modulators of the GPR119 receptor and the treatment of disorders related thereto
|
PT2672823T
(pt)
|
2011-02-07 |
2016-11-21 |
Biogen Ma Inc |
Agentes que modulam s1p
|
WO2012135570A1
(fr)
|
2011-04-01 |
2012-10-04 |
Arena Pharmaceuticals, Inc. |
Modulateurs du récepteur gpr119 et traitement de troubles qui lui sont associés
|
WO2012145361A1
(fr)
|
2011-04-19 |
2012-10-26 |
Arena Pharmaceuticals, Inc. |
Modulateurs du récepteur gpr119 et traitement de troubles liés à celui-ci
|
WO2012145604A1
(fr)
|
2011-04-22 |
2012-10-26 |
Arena Pharmaceuticals, Inc. |
Modulateurs du récepteur gpr119 et traitement de troubles liés à celui-ci
|
WO2012145603A1
(fr)
|
2011-04-22 |
2012-10-26 |
Arena Pharmaceuticals, Inc. |
Modulateurs du récepteur gpr119 et traitement de troubles liés à celui-ci
|
WO2012170702A1
(fr)
|
2011-06-08 |
2012-12-13 |
Arena Pharmaceuticals, Inc. |
Modulateurs du récepteur gpr119 et traitement de troubles associés à celui-ci
|
WO2013055910A1
(fr)
|
2011-10-12 |
2013-04-18 |
Arena Pharmaceuticals, Inc. |
Modulateurs du récepteur gpr119 et traitement de troubles associés
|
EA201491460A1
(ru)
|
2012-02-03 |
2015-01-30 |
Тева Фармасьютикал Индастриз Лтд. |
ПРИМЕНЕНИЕ ЛАХИНИМОДА В ЛЕЧЕНИИ ПАЦИЕНТОВ С БОЛЕЗНЬЮ КРОНА, У КОТОРЫХ НЕ ЭФФЕКТИВНА ТЕРАПИЯ ПЕРВОЙ ЛИНИИ АНТИ-TNFα
|
US20160038506A1
(en)
|
2012-02-14 |
2016-02-11 |
Repros Therapeutics Inc. |
Selective Estrogen Receptor Modulators With Short Half-Lives and Uses Thereof
|
US8962888B2
(en)
|
2012-12-03 |
2015-02-24 |
Physical Sciences, Inc. |
Forming spherical crystal habit
|
JP5589110B1
(ja)
|
2013-03-08 |
2014-09-10 |
株式会社ポーラファルマ |
晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
|
WO2016112075A1
(fr)
|
2015-01-06 |
2016-07-14 |
Arena Pharmaceuticals, Inc. |
Procédés de traitement de maladies associées au récepteur s1p1
|
SI3310760T1
(sl)
|
2015-06-22 |
2023-02-28 |
Arena Pharmaceuticals, Inc. |
Kristalinična L-argininska sol (R)-2-(7-(4-ciklopentil-3-(trifluorometil)benziloksi)-1,2,3,4- tetrahidrociklo-penta(b)indol-3-il)ocetne kisline za uporabo pri motnjah, povezanih z receptorjem S1P1
|
AU2018222747A1
(en)
|
2017-02-16 |
2019-09-05 |
Arena Pharmaceuticals, Inc. |
Compounds and methods for treatment of inflammatory bowel disease with extra-intestinal manifestations
|
CA3053418A1
(fr)
|
2017-02-16 |
2018-08-23 |
Arena Pharmaceuticals, Inc. |
Composes et methodes de traitement de l'angiocholite biliaire primitive
|
US20210228545A1
(en)
|
2018-06-06 |
2021-07-29 |
Arena Pharmaceuticals, Inc. |
Methods of treating conditions related to the s1p1 receptor
|
US20210386706A1
(en)
|
2018-10-03 |
2021-12-16 |
Arena Pharmaceuticals, Inc. |
Methods for the treatment of scleroderma
|
EP3886841A1
(fr)
|
2018-11-30 |
2021-10-06 |
Arena Pharmaceuticals, Inc. |
Méthodes de traitement d'états liés au récepteur s1p1
|
JP2022516662A
(ja)
|
2019-01-08 |
2022-03-01 |
アリーナ ファーマシューティカルズ, インコーポレイテッド |
S1p1受容体に関連する状態を治療する方法
|